The Koebner-phenomenon in epidermal growth factor receptor inhibitor-induced cutaneous adverse effects

Journal of Clinical Oncology

Volumn 26, Issue 16, 2008, Pages 2790-2792

  Gerber, Peter Arne ^a   Enderlein, Elaine ^a   Homey, Bernhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ADULT; AGED; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN TISSUE; ISOMORPHIC PHENOMENON; LETTER; LUNG NON SMALL CELL CANCER; MALE; MEDICAL DOCUMENTATION; PAPULE; PHOTOSENSITIVITY; PRIORITY JOURNAL; PUSTULE; RASH; SKIN BIOPSY; SKIN TOXICITY; TREATMENT DURATION; ULTRAVIOLET RADIATION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; LUNG TUMOR;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; EXANTHEMA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 45749133569     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.16.0077     Document Type: Letter

References (21)

1. Lacouture ME: Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 6:803-812, 2006
2. Soler R, Chachoua A, Hammond LA, et al: Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 22:3238-3247, 2004
3. Wacker B, Nagrani T, Weinberg J, et al: Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies. Clin Cancer Res 13:3913-3921, 2007
4. Luu M, Lai SE, Patel J, et al: Photosensitive rash due to the epidermal growth factor receptor inhibitor erlotinib. Photodermatol Photoimmunol Photomed 23:42-45, 2007
5. Weiss G, Shemer A, Trau H: The Koebner phenomenon: Review of the literature. J Eur Acad Dermatol Venereol 16:241-248, 2002
6. Woodworth CD, Michael E, Marker D, et al: Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol Cancer Ther 4:650-658, 2005
7. Jost M, Kari C, Rodeck U: The EGF receptor: An essential regulator of multiple epidermal functions. Eur J Dermatol 10:505-510, 2000
8. Arteaga CL: The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 19:32S-40S, 2001
9. Mendelsohn J, Baselga J: Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787-2799, 2003
10. Mascia F, Mariani V, Girolomoni G, et al: Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163:303-312, 2003
11. Pastore S, Mascia F, Mariotti F, et al: ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174:5047-5056, 2005
12. Mitra SS, Simcock R: Erlotinib induced skin rash spares skin in previous radiotherapy field. J Clin Oncol 24:e28-29, 2006
13. Gerber PA, Enderlein E, Homey B, et al: Radiation-induced prevention of erlotinib-induced skin rash is transient: A new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects. J Clin Oncol 25:4697-4698, 2007; author reply 4698-4699
14. Peus D, Hamacher L, Pittelkow MR: EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol 109:751-756, 1997
15. Kobayashi T, Hashimoto K, Okumura H, et al: Endogenous EGF-family growth factors are necessary for the progression from the G1 to S phase in human keratinocytes. J Invest Dermatol 111:616-620, 1998
16. Stoll SW, Benedict M, Mitra R, et al: EGF receptor signaling inhibits keratinocyte apoptosis: Evidence for mediation by Bcl-XL. Oncogene 16:1493-1499, 1998
17. Rodeck U, Jost M, Kari C, et al: EGF-R dependent regulation of keratinocyte survival. J Cell Sci 110:113-121, 1997
18. Peus D, Vasa RA, Meves A, et al: UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 72:135-140, 2000
19. Jost M, Gasparro FP, Jensen PJ, et al: Keratinocyte apoptosis induced by ultraviolet B radiation and CD95 ligation- differential protection through epidermal growth factor receptor activation and Bcl-x(L) expression. J Invest Dermatol 116:860-866, 2001
20. Sartor CI: Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol 1:80-87, 2004
21. Budach W, Bolke E, Homey B: Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 357:514-515, 2007